Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française.
Jacoulet P, Depierre A, Moro D, Rivière A, Milleron B, Quoix E, Ranfaing E, Anthoine D, Lafitte JJ, Lebeau B, Kleisbauer JP, Massin F, Fournel P, Zaegel M, Leclerc JP, Garnier G, Brambilla E, Capron F. Jacoulet P, et al. Among authors: quoix e. Ann Oncol. 1997 Oct;8(10):1009-14. doi: 10.1023/a:1008287922285. Ann Oncol. 1997. PMID: 9402175 Free article. Clinical Trial.
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
Pujol JL, Daurès JP, Rivière A, Quoix E, Westeel V, Quantin X, Breton JL, Lemarié E, Poudenx M, Milleron B, Moro D, Debieuvre D, Le Chevalier T. Pujol JL, et al. Among authors: quoix e. J Natl Cancer Inst. 2001 Feb 21;93(4):300-8. doi: 10.1093/jnci/93.4.300. J Natl Cancer Inst. 2001. PMID: 11181777 Clinical Trial.
Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000).
Depierre A, Lagrange JL, Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Bréchot JM, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Molina T, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stoebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V; FNCLCC. Depierre A, et al. Among authors: quoix e. Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S35-49. doi: 10.1038/sj.bjc.6601083. Br J Cancer. 2003. PMID: 12915902 Free PMC article. No abstract available.
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer.
Quoix E, Lebeau B, Depierre A, Ducolone A, Moro-Sibilot D, Milleron B, Breton JL, Lemarie E, Pujol JL, Brechot JM, Zalcman G, Debieuvre D, Vaylet F, Vergnenegre A, Clouet P. Quoix E, et al. Ann Oncol. 2004 Jan;15(1):38-44. doi: 10.1093/annonc/mdh005. Ann Oncol. 2004. PMID: 14679117 Free article. Clinical Trial.
284 results